Publication | Closed Access

Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis

NanomedicineNanotherapeuticsChitosan PolyEngineeringDrug Delivery SystemsTnf-ɑ SirnaNano-drug DeliveryBiomedical EngineeringUlcerative ColitisDrug Delivery SystemMedicine